Patients admitted to an intensive care unit (ICU) are subjected to a high burden of stress, rendering them prone to develop stress-related psychopathology. Dysregulation of inflammation and, more specifically, upregulation of inflammatory markers such as Creactive protein (CRP) is potentially key in development of post-ICU psychopathology.
Introduction
In the Netherlands, over 80,000 patients are admitted to the Intensive Care Unit (ICU) each year, and this number is increasing (https://www.stichting-nice.nl/). After discharge, healthrelated quality of life is largely determined by mental wellbeing (Iwashyna, 2010; Oeyen et al, 2010) . The increasing number of ICU survivors combined with a decrease in quality of life renders in-depth studies into determinants of mental health in this patient category timely.
Post-traumatic stress disorder (PTSD) and depression are prevalent mental disorders following ICU admission (Asimakopoulou & Madianos, 2014) . Several studies have demonstrated associations between acute high stress exposure due to ICU admission on the one hand, and PTSD and depression on the other (Davydow et al, 2013; Schelling et al, 2003) . Despite the burgeoning body of research highlighting increased incidences of PTSD and depressive symptoms in ICU survivors (Davydow et al, 2008; Davydow et al, 2009) , specific risk factors for developing post-ICU psychopathology remain largely undetermined. A better understanding of the potential mechanisms underlying the development of psychopathology after ICU admission could help to identify patients at risk of psychopathology following ICU stay.
Since dysregulated inflammatory cascades are present in a high number of ICU patients, these might influence the development of psychopathology after discharge (Dieleman et al, 2012; Iwashyna, 2010) . Evidence suggests that inflammation contributes to the development of PTSD and depression (Miller et al, 2009; Raison & Miller, 2011) , and -in particularincreased C-reactive protein (CRP) levels are reported to be associated with posttraumatic stress disorder (PTSD), depression, and psychological distress (Danner et al, 2003; Eraly et al, 2014; Wium-Andersen et al, 2013) .
Plasma CRP levels are highly affected by myriad state-dependent factors such as diet (King et al, 2003) , physical activity (Kasapis & Thompson, 2004) and transient systemic infections. To circumvent the influence of these confounding factors on the traits of interest, we applied Mendelian Randomization (MR), a design that enables assessment of causality between a risk factor and an outcome. MR is based on the assumption that state-dependent features and environmental factors are generally equally distributed over carriers and noncarriers of genetic variants (de Haan et al, 2014; van der Weele et al, 2014) . Thus, by taking genetic variants as proxies for circulating CRP (trait CRP), reverse causation and confounding are less likely to occur than when plasma CRP levels are considered (de Haan et al, 2014) .
A genome wide association study (GWAS) including over 80,000 individuals found three single nucleotide polymorphisms (SNPs) -rs2794520, rs4420638 and rs1183910 -to be strongly associated with circulating CRP levels (Dehghan et al, 2011) . The corresponding loci encompass the genes CRP, apolipoprotein C1 (APOC1) and hepatic nuclear factor 1-α (HNF1A), respectively (Dehghan et al, 2011) . Although other CRP-related SNPs have been investigated in the context of PTSD or depressive symptoms (Ancelin et al, 2015; Halder et al, 2010; Michopoulos et al, 2015; Prins et al, 2016) , the role that the abovementioned genetic variants play in ICU-related psychopathology have not been studied so far.
Here, we applied MR (including genetic risk scoring) to study the impact of trait CRP on psychopathology following ICU stay. We also investigated genetic pleiotropy between trait CRP and psychopathology following ICU stay. Our design has enabled us to assess causality, which to our knowledge had not been investigated to date.
Methods

Study design, participants and outcome measures
Data were drawn from the Dexamethasone for Cardiac Surgery study (DECS), a longitudinal follow up of patients from a multicenter, double-blind randomized controlled trial (Dieleman et al, 2012; Clinicaltrials.gov identifier NCT00293592, N=4494 participants) . The aim of this trial was to compare high-dose intravenous dexamethasone (1 mg/kg bodyweight, not exceeding 100 mg) with placebo administration in patients undergoing cardiac surgery who were subsequently submitted to the ICU. Eight cardiac surgery centers in The Netherlands participated, and the study was approved by all applicable research ethics committees (Dieleman et al, 2012) . The medical Ethics Committee of the University Medical Center Utrecht approved the current follow-up protocol. All subjects participating in the current study signed both the initial and additional informed consent forms.
Participants were recruited between April 13, 2006 and November 23, 2011 . DECS included 4494 randomized adult patients requiring a cardiopulmonary bypass during cardiac surgery. Of the original DECS study population, 2458 patients (recruited from five participating centers) were eligible for the follow-up study as the remainder had passed away or exceeded the inclusion criterion of maximum follow up time (i.e., 48 months after randomization).
PTSD symptoms were measured using the Self-Rating Inventory for PTSD (SRIP), a validated Dutch questionnaire (Hovens et al, 2002) . This 22 item questionnaire addresses DSM-IV-TR criteria of PTSD in the past four weeks. The validated Beck Depression Inventory (BDI-II) (Beck et al, 1998) was used to measure depressive symptoms. Items on both questionnaires are scored on a 0-3 Likert scale, with higher scores indicating more severe symptoms. For binary trait analyses, we rated symptoms of PTSD as present in the event of SRIP scores above the validated threshold of 39, which was the case in 10.8% of all participants, comparable to what has been described in previous studies (van Zelst et al, 2003) . Symptoms of depression were present in 13.2% of all participants, after applying threshold of 13.5 to the BDI-II score (Dozois et al,1998) . A detailed description of the patient selection and measurements is reported elsewhere (Kok et al, 2016) . For the analyses in this study, we log transformed SRIP and BDI-II variables due to non-normal distributions.
Genotyping procedures
Genomic DNA was extracted from saliva using salivettes (Kleargene™ XL nucleic extraction kits) according to the manufacturer's protocol. Quantity of DNA was measured using Quant- Allelic discrimination was determined by the post-read stage fluorescence intensity using QuantStudio™ 6 genotyping software.
Statistical analyses
Descriptive statistics were generated using Statistical Package for Social Sciences (SPSS Inc., version 20.0. IBM corp. Chicago, IL, USA), while genetic analyses were performed using PLINK v1.07 (Purcell et al, 2007) and R (www.r-project.org) . Missing values at baseline and psychopathology outcome variables were imputed using multiple imputation in SPSS. Ten imputed datasets were created based on independent and dependent variables. Analyses were conducted in each dataset and results were pooled according to Rubin's rule (Rubin, 1987 All effect sizes were in standard deviation units for continuous traits and log odds ratios for disease and binary traits. The standard error (SE) was estimated using the delta method (Bautista et al, 2007; Thomas et al, 2007) . marker is conditionally independent of measured/unmeasured confounders), as well as the NO Measurement Error (NOME) assumption (Bowden et al, 2016) . Moreover, the more robust MR-Egger method (Spring et al, 1989 ) was applied to investigate potential directional horizontal pleiotropy. The high I 2 statistic (>90% in our study) supports the MR assumption of NOME. In addition, leave-one-out analysis was performed (Stone, 1974) . In line with the abovementioned quantitative traits studies, per-SNP logistic regression to assess single-SNP effects was performed first, followed by logistic regression on GRS calculated from the three SNPs, and concluded with fixed-effects meta-analysis.
Finally, to assess whether effects of CRP-associated SNPs are specific to post-ICU admission psychopathology or also generalizable to 14 other psychiatric disorders, we used the MR-base package (Hemani et al, 2016) , aiming to investigate any causal relationships between CRP and such phenotypes, based on the abovementioned three leading CRPassociated SNPs. If these candidate SNPs could not be extracted from the statistical data summary, we extracted a proxy SNP instead (the most informative SNP having highest LD r 2 -value). The significance threshold was again Bonferroni corrected (a=0.05/14=0.0036).
Results
Demographics and clinical characteristics
The study population consisted of 1093 subjects for whom signed informed consent, returned completed questionnaires and sufficient DNA were available ( Figure S1 ). The median age of the participants was 69 years (interquartile range (IQR): 63-76) and ranged between 26 and 91 years. The majority of patients were male (78%). Dexamethasone was administered to 49.8 percent of the participants while 50.2 percent received placebo. Patients were admitted to the ICU for 5 to 1800 hours with a median duration of stay of 21 hours (IQR: 18.5-23.5). Demographic and clinical characteristics are displayed in Table 1 .
Genotyping success rates and Hardy-Weinberg equilibrium
The genotyping success rates for rs2794520, rs4420638 and rs1183910, were 97.7, 96.5, and 97.5 percent, respectively. All three SNPs were in Hardy-Weinberg equilibrium (HWE; p=1.0; p=0.076, and p=1.0, respectively) and the minor allele frequencies (MAFs) were 0.3455, 0.1909 and 0.2935, which is in agreement with the 1000 Genomes project (http://www.1000genomes.org). Genotype distributions are presented in Table S1 .
Mendelian randomization analyses
None of the three SNPs was individually associated with PTSD or depressive symptoms at the Bonferroni-corrected significance threshold (α=0.017; Table 2a and 2b). rs2794520 showed nominal evidence of association with quantitative PTSD symptoms (β: 0.2142, p=0.0325) and with quantitative depression symptoms (β: 0.2203, p=0.0273): the CRP-decreasing T-allele (which is also the minor allele) was associated with increased risk of psychopathology following ICU stay (Figure 1a and 1b) . Logistic regression showed no significant results for the binary traits either: presence of the T-allele of rs2794520 tended to increase the risk of depression (OR=1.811, p=0.051) and PTSD (OR=1.409, p=0.316) non-significantly.
When applying GRS, the proportions of variances of quantitative and binary PTSD and depressive symptoms explained by the CRP loci were non-significant (p>0.05) and below 0.0035 in both models ( Figure S2 ).
Meta-analysis of the effects of the three CRP SNPs on PTSD and depressive symptoms was similarly negative ( Figure S3 , Figure S4 , and Table S2a ). There was no evidence of heterogeneity (p=0.02). MR-Egger regression (Table S2b ) consistently showed no causal effects: the I 2 statistic (indicating the level of instrument bias in the context of MREgger) was high (>90%). Therefore, the expected relative dilution did not affect the standard MR-Egger analyses for our data. Directional horizontal pleiotropy of CRP and psychopathological outcomes was absent (p-pleiotropy>0.05). Leave-one-out sensitivity analyses ( Figure S5 ) showed none of the SNPs altering pooled effect sizes, indicating reliable and stable meta-analytic results. In line with this, parallel binary trait analysis showed no association between either individual SNPs or GRS on the one hand and psychopathology outcomes on the other, pleading against a causal relation between CRP-levels and psychopathology.
Finally, estimation of causality between the three CRP SNPs and 14 other psychiatric disorders by MR-base showed that level of CRP does not significantly affect the occurrence of other neuropsychiatric diseases (Table 3) . No directional horizontal pleiotropy effects were detected among CRP and these neuropsychiatric traits.
Discussion
The present study was designed to examine the potential effect of trait CRP on PTSD and depressive symptoms in a large cohort of ICU survivors (N=1093). Overall, no evidence for a causal relationship between trait CRP and psychopathology after ICU-stay was found. In addition, we demonstrated that these traits are unlikely to share non-polygenic genetic overlap. Finally, we showed that the absence of causal effects of plasma CRP also applies to other neuropsychiatric traits. Since these disorders share many risk factors, which further pleads against a role of CRP in the development of psychopathology. Considering the many MR assumptions, negative MR findings are particularly valuable (van der Weele et al, 2014) .
Provided the genetic variants are strongly associated with the exposure -which is the case in this study -negative MR findings more strongly advance insights into relationships between exposures and traits than positive MR findings (van der Weele et al, 2014) . Moreover, a null association (with a narrow confidence interval) between a strong instrument and an outcome provides more robust evidence of no or a very small causal effect.
Several factors may explain these findings. First, being admitted to an ICU is commonly perceived as stressful and this may trigger the development of PTSD and depressive symptoms (Schelling et al, 2003; Davydow et al, 2008) . Thus, environmental factors (e.g. illness severity and duration of stay) may be stronger determinants of psychiatric outcomes following ICU stay than genetic underpinnings. Elevated levels of CRP in the context of psychopathology as detected in previous studies (Danner et al, 2003; Eraly et al, 2014; Wium-Andersen et al, 2014) may also occur due to other mechanisms, such as reversed causation, where PTSD and/or depressive symptoms cause elevated CRP levels rather than vice versa. Upregulation of inflammatory markers -e.g. state CRP -could therefore still be part of the pathophysiological pathway involved with the development of stress-related psychopathology (Duivis et al, 2013; von Känel et al, 2007) . Future studies combining plasma CRP levels with MR could provide a more-refined understanding of the relationship between CRP levels and psychopathology (Almeida et al, 2009; Wium-Andersen et al, 2014) .
Furthermore, CRP-related genetic mechanisms other than single-locus effects -e.g., epistasis
(for which this study was underpowered) and epigenetics -may influence the relationship between CRP and psychopathology. Finally, our power analysis indicates that our model had 80% power to detect an effect size of 0.007. This indicates that our study was adequately powered to detect medium to large effects, but underpowered to pick up very small effects (Freeman et al, 2013) .
Although a positive association between CRP and psychopathology has been observed (Wium-Andersen et al, 2014; Ma et al, 2010) , causal effects of CRP-associated loci on neuropsychiatric diseases had remained debatable. A recent MR study of CRP with multiple complex traits in a European study population, in which two CRP genetic risk scores as instrumental variables were used, showed no causality between CRP and autism, bipolar disorder, Parkinson's disease, major depressive disorder, and a negative effect on schizophrenia (i.e., elevated levels of CRP are not predisposing but in fact protective) (Prins et al, 2016) . Similarly, in our MR-based study, a suggestive but nevertheless consistently negative effect on schizophrenia was detected (p=0.014, which was the lowest p-value among 14 psychiatric traits) (Dehghan et al, 2011; Ripke et al, 2014) . Although the negative effect on schizophrenia was not significant after correction for multiple testing, the validation of this result requires further investigation of more CRP-associated SNPs. No significant directional horizontal pleiotropy for the three CRP-associated SNPs was detected in a broad selection of psychiatric disorders (p-pleiotropy >0.05), implying these psychiatric disorders and state CRP levels are not associated with the CRP genetic variants via separate pathways.
Since other studies implicate different CRP polymorphisms from the ones we It is important to bear in mind that this study addressed a cardiac surgery cohort. In general, these are relatively healthy patients who are only admitted to the ICU overnight.
Nevertheless, cardiovascular disease has been associated with inflammatory dysregulation in general (Bot & Kuiper, 2017) . Differentiation between the effect of ICU treatment and genetic predisposition for the development of PTSD and depression is therefore challenging in our study population. Targeting phenotypically more diverse cohorts of critically ill patients may result in a more fine-grained understanding of the relationship between trait CRP and psychopathology. On the other hand, strengths of our study comprise the investigation of the most strongly associated CRP genetic loci, the high genotyping success rates and the stringent and comprehensive statistical analyses including several sensitivity analyses, while correcting for multiple testing and relevant covariates.
In conclusion, based on our MR method it is unlikely that trait CRP and 
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